CRVO · CervoMed Inc.
$2.60
-0.04 (-1.52%)
At close · Aug 28
Going-concern doubt
— cleared Aug 7, 2026
The latest filing no longer states the doubt (first flagged May 15, 2026).
View the 10-Q filed Aug 7, 2026Market Cap
$39.76M
Shares
15.12M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| William K. Hornung | Chief Financial Officer | $355,134 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| David G. Kalergis | Chief Executive Officer | $587,141 |
| John L. Gainer | Former Chief Scientific Officer | $507,037 |
| William K. Hornung | Chief Financial Officer | $381,462 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David Quigley | director | Appointed | 2025-10-29 |
| Mark De Rosch | Executive Vice President, Regulatory and Government Affairs and Program Management | Appointed | 2025-04-18 |
| Kelly Blackburn | Executive Vice President, Clinical Development | Appointed | 2025-04-18 |
| William Tanner | Chief Financial Officer | Terminated | 2024-05-20 |
| William Elder | Chief Financial Officer | Appointed | 2024-05-20 |
| Joshua S. Boger, Ph.D. | director | Appointed | 2024-02-07 |
| Joshua S. Boger, Ph.D. | Chair of the Board | Appointed | 2024-02-07 |
| J. William Tanner, Ph.D. | Chief Financial Officer | Appointed | 2023-11-17 |
| Robert J. Cobuzzi, Jr., Ph.D. | director | Appointed | 2023-11-08 |
| Jill Davidson | Board of Directors | Resigned | 2023-10-31 |
| Frank Zavrl | Director | Appointed | 2023-08-17 |
| John Alam, M.D. | Director | Appointed | 2023-08-17 |
| Sylvie Grégoire, Pharm.D. | Chair of the Board of Directors | Appointed | 2023-08-17 |
| Jeff Poulton | Director | Appointed | 2023-08-17 |
| Marwan Sabbagh, M.D. | Director | Appointed | 2023-08-17 |
| William Tanner, Ph.D. | Chief Financial Officer (Principal Financial Officer) | Appointed | 2023-08-17 |
| John Alam, M.D. | Chief Executive Officer, President and Director (Principal Executive Officer) | Appointed | 2023-08-17 |
| Kelly Blackburn, M.H.A. | Senior Vice President, Clinical Development | Appointed | 2023-08-17 |
| William Elder | Principal Financial Officer | Resigned | 2023-08-17 |
| Robert J. Cobuzzi, Jr., Ph.D. | Chief Operating Officer | Appointed | 2023-08-17 |
| Robert J. Cobuzzi, Jr., Ph.D. | Chief Executive Officer | Resigned | 2023-08-17 |
| Diana Lanchoney, M.D. | member of the Company's board of directors | Resigned | 2023-08-17 |
| Robert J. Cobuzzi, Jr., Ph.D. | director of the Company | Resigned | 2023-08-17 |
| Robert Adams, J.D. | member of the Company's board of directors | Resigned | 2023-08-17 |
| Mark T. Giles, J.D. | member of the Company's board of directors | Resigned | 2023-08-17 |
Key facts
CIK
1053691
CUSIP
15713L109
13F (30d)
36 filings
35 filers
Visit website
Investor relations